Non-Dilutive Funding for Life Sciences Innovations
Funding pre-clinical research and clinical trials without sacrificing equity.
The Unique Funding Challenges of Life Sciences
Funding can be very complex and challenging.
Development
Long Development Cycles (Time-to-Market)
Regulatory
The journey to market is dictated by strict regulatory phases
Protection
Securing and defending foundational patents requires capital
Specific Risk
Perceived risk of unproven, novel technologies
Our Solutions
Built for founders of life science innovations. Trusted by funders. Designed for scale in Europe.
Funding starts with strategy and we build yours for the long game.
We define your non-dilutive roadmap before diving into applications, aligned with product milestones and capital needs.
Applying for public grants and loans without a solid strategy is like building on sand. Our modular approach starts with research and roadmap alignment, ensuring every application supports your product development, go-to-market motion and investor timeline.
We do not just list potential programs. We filter for relevance, connect funding with business milestones and identify the optimal mix of grants, loans and future equity. Our focus is always on maximizing non-repayable grants because they are the most founder-friendly form of capital – no repayment, no equity given up.
- Market & funding research
- Strategic alignment with roadmap and financing
- Ideal grant/loan mix design
- Strategy for up to three years
Grants - without the guesswork.
Based on hundreds of success cases, we handle the full process – AI-assisted, human-validated.
Based on numerous of successful cases, we write your entire application package using AI-backed best practices and proven frameworks. You receive a ready-to-submit application, support with all annexes, and help answering follow-up questions, so you can focus on your business, not bureaucracy.
- Full drafting of all required documents by our experts
- AI-supported writing based on numerous of successful applications
- Support during submission and follow-up communication
- Only 1 to 3 hours of your time required — we handle the rest
Low-interest loans that align with your growth - not dilute your cap table.
We help you secure the right public loans from KfW, IBB and EU-backed institutions. From financial planning to coordination with your bank – we take care of everything.
Public loans are a powerful tool to finance product development, hiring, or working capital, without giving up equity. We support you throughout the entire process: selecting the best-fitting loan program, preparing all required documents, and aligning the loan with your overall funding and investor strategy.
Our experts prepare your business plan, financial forecast, and annexes based on proven templates and bank expectations. We coordinate with your local bank if needed and ensure the loan process runs smoothly.
- Selection of the best-fitting loan program (KfW, IBB, EU-backed, etc.)
- Full preparation of business plan and financial forecast
- Coordination with your house bank or funding partner
- Minimal time effort for founders , we handle the paperwork
FAQs
What our clients often ask before they get started.
Why is non-dilutive financing so critical for Life Sciences?
It is vital for survival. The sector’s high failure rate and huge costs mean equity is precious. Non-dilutive capital funds critical, high-risk stages like pre-clinical and Phase I trials, preserving founder control.
Do these grants cover all the costs of a clinical trial?
Grants often cover significant portions of the research and development (R&D) costs and specific trial phases. We design a “blended finance” strategy to combine grants with strategic debt to fund the entire trial pathway.
How do you help manage the regulatory documentation burden?
Our strategy involves aligning your funding milestones directly with your regulatory strategy (e.g., EMA meeting). We ensure all financial documentation supports the technical and regulatory narrative required by the funding body.
What types of startups qualify as Life Sciences innovators?
Companies developing biotech therapies, diagnostics, medical devices, digital health tools, and gene and cell therapies typically qualify.
Are there grants available for life sciences startups?
Yes, state, national and EU programs provide non-dilutive grants for early research, clinical trials, and innovation projects, supporting risk reduction.
We are a university spin-off, what is our best first step?
Your best first step is to secure seed non-dilutive funding like the EXIST grant.
